Plasma Fractionation Market to Grow with a CAGR of 6.32% through 2030

Surge in research and development activities is expected to drive the Global Plasma Fractionation Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Plasma Fractionation Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Plasma Fractionation Market stood at USD 25.78 Billion in 2024 and is anticipated to grow with a CAGR of 6.32% through 2030. Initiatives taken by government based on plasma fractionation has led to favorable market conditions for the Global Plasma Fractionation Market. Several factors contribute to the growth of various plasma fractionation products.

R&D efforts are leading to the development of more advanced fractionation techniques, such as improved chromatography and membrane-based separation technologies, which allow for higher purity, greater recovery rates, and shorter production cycles. These technological advancements not only improve operational efficiency but also reduce the risk of contamination, ensuring enhanced patient safety and regulatory compliance. Another key focus of R&D in the plasma fractionation sector is the identification of new indications for plasma-derived therapies.

One key area of government focus is the establishment and expansion of national blood and plasma collection programs. Countries such as the United States, Australia, and several in the European Union have implemented policies to increase voluntary plasma donations, improve donor safety, and ensure sufficient plasma supply to meet domestic therapeutic demand. In many cases, governments have partnered with private sector companies or non-profit organizations to enhance the efficiency of collection networks and promote ethical sourcing practices.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Plasma Fractionation Market”

The Global Plasma Fractionation Market is segmented into product, application, regional distribution, and company.

Based on Product, Immunoglobulins have emerged as the dominating segment in the Global Plasma Fractionation Market in 2024. One of the key drivers of this segment’s leadership is the growing prevalence of immunodeficiency diseases, both congenital and acquired. Immunoglobulin therapies, particularly intravenous (IVIG) and subcutaneous (SCIG) formulations, are essential for replacing missing or deficient antibodies in affected individuals, making them a cornerstone in immunology and hematology treatment protocols. Furthermore, immunoglobulins are increasingly used in the management of autoimmune and inflammatory conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barré syndrome, and immune thrombocytopenia (ITP), significantly expanding their clinical relevance.

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global Plasma Fractionation Market in 2024. This is driven by rising demand for plasma-derived therapies, increasing healthcare investments, and expanding diagnostic capabilities. The region is witnessing a surge in chronic conditions such as immunodeficiency disorders, hemophilia, and liver diseases, which require plasma-derived products for effective management. This rising disease burden is accelerating the need for robust plasma fractionation services across the region.

Major companies operating in Global Plasma Fractionation Market are:

• Grifols S.A.
• Octapharma AG
• Intas Pharmaceuticals Ltd
• LFB S.A.
• Takeda Pharmaceutical Company Limited
• CSL Limited
• Biotest AG
• Kedrion S.p.A
• Bio Products Laboratory Ltd.
• Bharat Serums and Vaccines Limited

Download Free Sample Report

Customers can also request for 10% free customization on this report

“One of the key applications of nanotechnology in plasma fractionation lies in the development of nanoporous membranes and nanomaterials that allow for high-specificity filtration and separation at the molecular level. These nano-enabled systems can isolate specific plasma proteins, such as immunoglobulins, albumin, and clotting factors, with greater yield and purity compared to conventional techniques. Additionally, nanostructured adsorbents are being integrated into chromatographic processes to enhance the selectivity and throughput of protein isolation”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), By Application (Neurology, Hematology, Oncology, Immunology, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Plasma Fractionation Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Plasma Fractionation Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com